Taipei, June 9 (CNA) Medigen Vaccine Biologics Corp., a Taiwan-based biopharmaceutical company, said Wednesday it is ready to present the data from the Phase II clinical trials of its COVID-19 vaccine candidate.
Over the past week, the US media and the Biden administration have sought to legitimize the conspiracy theory that the world’s leading scientists were engaged in a cover-up of the “Wuhan lab” origins of COVID-19.
Purpose: The deposition of hydroxyapatite (HAp) crystals plays an important role in the development of vascular calcification (VC). This study aimed to demonstrate the effects of nanosized HAp (nHAp) on vascular smooth muscle cells (VSMCs) and VC progression.
Methods: Transmission electron microscopy (TEM) was used to examine cellular uptake of nHAp. Cell viability was determined using CCK-8 assay kit. Mitochondrial impairment and reactive oxygen species were detected by TEM and fluorescence dye staining, respectively. Cell apoptosis was detected by Western blot analysis and Annexin V staining. Mouse model of VC was built via applying nHAp on the surface of abdominal aorta. Calcification was visualized by Alizarin red and von Kossa staining.
Results of the COLCORONA study published in The Lancet Respiratory Medicine | Comunicados | Edición USA efe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from efe.com Daily Mail and Mail on Sunday newspapers.
Results of the COLCORONA study published in The Lancet Respiratory Medicine - News Makers newsmakers.pk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmakers.pk Daily Mail and Mail on Sunday newspapers.